Why Your Face Sags After 40: It Might Be Your Skull, Not Just Your Skin

Executive summary

  • This note examines why the face changes shape with age, and questions the common assumption that facial ageing is primarily a problem of the skin.

  • It reviews the evidence that the facial skeleton itself remodels and recedes with age, drawing on three-dimensional CT imaging.

  • It explains the structural consequence: as the bony scaffold recedes, the overlying skin and fat lose their support, which contributes to what we perceive as sagging.

  • It examines the reported association between facial wrinkling and low bone density, and is careful about what that association can and cannot show.

  • It assesses the two practical responses: dermal filler (what it can and cannot do), and protecting the skeleton itself through nutrition, mechanical load, micronutrients and dental health.

  • It considers the specific case of women around menopause, when falling oestrogen accelerates bone loss.

  • It closes with a measured practical summary, and discloses my commercial interests in full.

Introduction

When a patient in her forties or fifties tells me her face is "dropping", she almost always means her skin. The working assumption, shared by patients and by a good deal of my own profession, is that facial ageing is a surface problem: collagen is lost, the skin loosens, and it sags. That is part of the story. It is not the whole of it. A substantial and under-discussed contributor is that the facial skeleton beneath the skin changes shape with age. The bones recede, and the soft tissue that was draped over them loses its support.

I should state my background and my biases at the outset. I trained originally in dentistry, a discipline that spends years on the anatomy of the skull and face. I subsequently completed postgraduate training in dermatology, a qualification in anti-aging medicine, and a separate qualification in metabolic medicine. I also offer private consultations. I set all of this out now so that you can weigh what follows accordingly.

The facial skeleton is not fixed

It is tempting to think of the skull as inert, but bone is living tissue that is continually rebuilt. Two populations of cells do this work: osteoclasts, which dissolve old bone, and osteoblasts, which lay down new bone. A useful analogy is a demolition crew and a building crew working the same site in shifts. In youth, with sex hormones and nutrition in reasonable order, the two are roughly matched. Most people reach peak bone mass somewhere around the mid-twenties, depending on diet and lifestyle, and thereafter the balance tips: a little more is removed than is replaced. The bones of the face are not exempt from this.

What the imaging shows

The clearest evidence comes from three-dimensional CT studies that compared the facial skeletons of younger and older adults. The best known, by Shaw and colleagues, reported that with age the angle of the midface flattens, the eye sockets enlarge (particularly at the outer edges), the pyriform aperture (the bony opening of the nose) widens, and the jaw loses height (Ref 1). These are not subtle differences visible only to specialists; on a scan, an older facial skeleton can often be distinguished from a younger one by shape alone.

The limitation to keep in mind is that these are cross-sectional comparisons of different people at different ages, not the same faces tracked over time. They demonstrate a consistent pattern of age-related change; they do not, on their own, quantify how fast it happens in any one individual.

Why receding bone produces sagging

The structural logic is straightforward. Consider a marquee, the kind erected for an outdoor event. The skin is the canvas, the fat and muscle beneath it are the lining, and the facial bones are the poles. If a pole is shortened, the canvas above it slackens and drapes, not because the canvas has deteriorated but because it has lost its support. The same principle applies to a face whose underlying bone has receded.

How much of any individual's sagging is due to bone rather than skin cannot be judged from a distance, and I would not attempt to. In younger people the dominant factor is more often skin laxity and the redistribution of facial fat. From the forties onward, loss of bony support becomes a more plausible contributor, and for many people it is a combination of both. The point of this article is not that skin is irrelevant, but that the skeleton is routinely left out of the conversation.

Skin and bone: a shared loss of collagen

There is an intriguing line of evidence linking the two. As part of the KEEPS hormone study, a team at Yale examined women in early menopause who were not taking hormone therapy and reported that the more numerous and deeper a woman's facial wrinkles, the lower her bone density at the hip, spine and heel, independent of age and body mass (Ref 2).

This finding is easy to over-interpret, so it is worth stating its limits plainly. It is an association, not a demonstration of cause and effect; the sample was not large; and no mechanism was established by the study itself. Facial wrinkling is therefore not a substitute for a bone-density (DEXA) scan. What makes the association biologically plausible, rather than merely coincidental, is that skin and bone are both built substantially from collagen, and both appear to lose it in parallel. It is reasonable to regard skin quality and skeletal quality as two visible expressions of the same underlying process, while stopping short of claiming that one predicts the other in an individual.

Why this is rarely discussed in the clinic

If skeletal change is so central, why is it seldom raised? The explanation is largely structural, and I make it without wishing to disparage colleagues, most of whom were taught this anatomy alongside me. A patient presents with a visible complaint, and the tools available within a short consultation act on the visible complaint. There is an injectable for lost volume; there is no injectable for a maxilla that has receded over fifteen years. There is also an incentive structure worth acknowledging honestly: the skeletal side of facial ageing is preventive and slow, and it does not generate revenue in the way a procedure does. None of this requires bad faith; it is simply where the incentives lead.

Response 1: dermal filler, and its limits

This explains why filler is so often reached for when a patient presents with midface flattening, and in many cases that is a reasonable response. Filler cannot replace bone, but it can be placed over an area of bony recession to restore volume, and in competent hands, with an appropriate product, the result can look natural for a period of time.

The important qualification is that filler is being asked to compensate for a foundation that continues to recede beneath it. As the bone loss progresses, more filler tends to be required, and this is one route to the over-filled appearance that most practitioners, myself included, dislike. The filler has not malfunctioned; it has been asked to perform a structural role it was not designed for. My own position is not against filler, which I use in practice, but in favour of treating the foundation and the surface as separate questions, and of being candid with patients that volume placed on a shrinking base is a holding measure rather than a correction.

Response 2: protecting the skeleton

The more durable response is to look after the skeleton itself. Three levers have reasonable support.

Raw materials. Bone is, by weight, largely collagen, and collagen is built from amino acids, predominantly glycine and proline, arranged in a triple helix. Adequate high-quality protein is therefore not optional. Animal foods provide these amino acids in their most bioavailable form, along with the minerals and fat-soluble vitamins that bone metabolism draws on. The relative bioavailability of animal versus plant protein is not seriously disputed in the nutrition literature, and it is the basis on which I encourage patients to prioritise animal sources.

Mechanical load. Bone adapts to the forces placed on it, a principle long known as Wolff's Law. Osteoblasts are prompted to build bone by mechanical stress; remove the stress, as happens in prolonged bed rest or in spaceflight, and bone is lost. The best randomised evidence in postmenopausal women, the LIFTMOR trial, found that supervised heavy resistance and impact training improved bone density in a group often advised to avoid such loading (Ref 3). The important caveat for the face is that loading is largely site-specific: a heavy squat loads the spine and hips, not the maxilla. For the facial skeleton the relevant load is chewing, discussed below, and the wider benefit is systemic.

Micronutrients. The long-standing advice to supplement calcium and vitamin D has produced, at best, modest results, and there is a reasonable concern that calcium taken without adequate vitamin K2 may be deposited in arterial walls rather than bone. The biochemistry of K2 is well characterised: it activates the proteins that direct calcium toward bone. The human trial evidence, however, is mixed. A three-year trial of MK-7 in postmenopausal women with osteopenia found no benefit over placebo on bone density (Ref 4), whereas a study by Knapen and colleagues reported improved bone microarchitecture (Ref 5), and pooled analyses sit between the two (Ref 6). My reading is that the trials are limited by an unavoidable problem: it is not possible to control the background diet of free-living participants, so a null result cannot distinguish between "K2 does not help" and "the rest of the diet was too poor for it to help." I therefore weight the established biochemistry more heavily than I might otherwise, while acknowledging that this is a judgement, not a settled conclusion. The practical position is that micronutrients support the diet and the loading; they do not substitute for them.

Dental health and the jaw. The jaw is part of the facial skeleton, and its principal daily load is chewing. When the diet shifts to soft foods, that load is withdrawn, and the bone thins. The most striking clinical illustration is tooth loss: the section of jawbone that supported an extracted tooth resorbs once it stops receiving load, a well-recognised observation in dentistry. Retaining natural teeth, and eating foods that require chewing, both help to preserve the lower face.

Women, oestrogen and menopause

The picture changes markedly for women around menopause. Oestrogen restrains the bone-dissolving osteoclasts; when it falls, that restraint is lifted, and the years immediately following the final period are when bone is lost most rapidly. Skeletal facial ageing may therefore accelerate over the same interval.

Hormone replacement therapy is one legitimate response, and I am qualified to prescribe it. My own clinical preference, stated as a preference rather than a directive, is to address diet, load and the wider metabolic picture first, because I have seen these measures resolve a good deal of menopausal symptom burden in practice, after which the original case for prescribing may be weaker. Where HRT remains the right choice for a particular woman, it is a reasonable one, and the nutritional and loading measures described above matter regardless of that decision.

The soft tissue, and a disclosed interest

None of the above should imply that the skin is unimportant. Above the bone, the fibroblasts of the dermis produce collagen, elastin and fibronectin, and their output declines with age. Supporting that output is a large topic in its own right.

Here I must disclose an interest. The nutraceutical I personally use to support skin quality, Nutrakos, is formulated to stimulate the body's own production of multiple collagen types, together with elastin and fibronectin. I have a personal bias to it, so please treat this as a disclosed bias and evaluate the evidence for yourself rather than on my say-so.

Conclusion

The practical message is unglamorous. The measures that best preserve the shape of the face over decades are the same ones that preserve the skeleton generally: sufficient high-quality protein, genuine mechanical loading of the body and regular chewing for the jaw, an adequate micronutrient base, attention to oestrogen status around menopause, and the retention of one's own teeth. Filler has a place, but as a surface measure layered on top of these, not as a substitute for them. None of this requires perfection; optimising the large factors most of the time leaves ample room for ordinary enjoyment. It does, however, require attention to a structure that the usual conversation about ageing skin leaves out.

Disclosures

I offer private consultations, and I run an online community in which I discuss this kind of material in more depth; details for both are available via my site. I would add that a regular, long-term relationship with a good local clinician is, for most people, more valuable than any single consultation with me.

References

  1. Shaw RB Jr, et al. Aging of the facial skeleton (three-dimensional CT analysis). Plastic and Reconstructive Surgery, 2011. https://pubmed.ncbi.nlm.nih.gov/17230106/

  2. Pal L, et al. (KEEPS ancillary analysis), reported by Yale Medicine: deeper facial wrinkles associated with lower bone density in early-menopausal women; presented at the Endocrine Society annual meeting, 2011. https://medicine.yale.edu/news-article/not-just-skin-and-bones-wrinkles-could-predict-womens-bone-fracture-risk/

  3. Watson SL, Weeks BK, Weis LJ, Harding AT, Horan SA, Beck BR. High-Intensity Resistance and Impact Training Improves Bone Mineral Density and Physical Function in Postmenopausal Women With Osteopenia and Osteoporosis: The LIFTMOR Randomized Controlled Trial. Journal of Bone and Mineral Research, 2018;33(2):211-220. https://doi.org/10.1002/jbmr.3284

  4. MK-7 (vitamin K2), three-year randomised trial in postmenopausal osteopenia (null result). https://pubmed.ncbi.nlm.nih.gov/33030563/

  5. Knapen MHJ, et al. MK-7 and bone microarchitecture. https://pubmed.ncbi.nlm.nih.gov/27625301/

  6. Vitamin K2 and bone health, pooled meta-analysis. Frontiers in Public Health, 2022. https://www.frontiersin.org/journals/public-health/articles/10.3389/fpubh.2022.979649/full

Previous
Previous

Hyaluronic Acid: Molecular Weight, CD44, and Why It Is Not Simply a Moisturiser